FALSE CLAIMS ACT POPULAR FOR OFF-LABEL USE PROMOTIONS

Washington Drug Letter
KEYWORDS Advertising / courts
A A

Drugmakers involved in potential off-label promotions of their products need to be wary of a new tactic used by prosecutors that has greater financial consequences than FDA enforcement activities under the Food, Drug and Cosmetic Act: prosecution under the False Claims Act.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $10.00